|
The device evaluation is ongoing.Prior to the device evaluation, the device was sent out for additional microbiological testing.The microbiological analysis results are pending.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
|
|
This report is being supplemented to provide additional information based on the legal manufacturer's (lm) review of the third-party testing, the device evaluation and the lms final investigation.Despite good faith attempts the user cleaning disinfection and sterilization (cds) processes were not shared.The user facility provided the following result of the culture test, performed at the third-party labs: sampling date: on (b)(6) 2024, sampling from: all channels, cfu: 5 cfu/100ml, bacterial identification: n/a.Olympus provided the following result of the culture test, performed at the third-party labs: sampling date: on (b)(6) 2024, sampling from: all channels, cfu: <1cfu, bacterial identification: n/a.The device was evaluated where no abnormalities were found that could have led to the reported event.A review of the device history record found no deviations that could have caused or contributed to the reported issue.Based on the results of the investigation, a root cause could not be determined.Growth of microorganisms were found through culture testing by the user after reprocessing.However, when olympus culture tested after reprocessing in accordance with the ifu before repair, the results conformed to the regulation's recommendation.The following is included in the device ifu: chapter 4 reprocessing workflow for endoscopes and accessories.Chapter 5 reprocessing the endoscope.Olympus will continue to monitor field performance for this device.
|